Literature DB >> 3263001

Günther vena caval filter: results of long-term follow-up.

F Fobbe1, M Dietzel, R Korth, D Felsenberg, S Bender, M Hamed, C Laass, R Sörensen.   

Abstract

A Günther vena caval filter was implanted in the inferior vena cava in 59 patients to prevent pulmonary embolism. This newly available device, which can be inserted percutaneously via a 10-French introduction system, has three filtering planes. No complications occurred at the puncture site. Follow-up included clinical examinations (54 patients), plain radiographs (50 patients), and CT scans (41 patients); these examinations were performed up to 21 months after implantation. Caudal migration of the filter occurred in 35 (70%) of the 50 patients who had radiographs, but no cranial or oblique movement occurred. Occlusion of the filter was noted in three (7%) of 41 patients who had CT examinations. Thromboemboli were seen inside the filter in 16 (39%) of the 41 patients who had CT scans. Recurrent pulmonary embolism was not observed after filter implantation. The Günther vena caval filter seems to be a satisfactory device for preventing pulmonary embolism.

Entities:  

Mesh:

Year:  1988        PMID: 3263001     DOI: 10.2214/ajr.151.5.1031

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Follow-up after partial interruption of the vena cava with the Günther filter.

Authors:  P A Schneider; P Geissbühler; J C Piguet; H Bounameaux
Journal:  Cardiovasc Intervent Radiol       Date:  1990-12       Impact factor: 2.740

2.  Failure of the intracaval filter of Günther to prevent recurrence of pulmonary embolism--report of two cases.

Authors:  F Lofaso; A A Messadi; M C Anglade; Y Huet
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Long-term follow-up of the Günther basket inferior vena cava filter: does mechanical instability cause complications?

Authors:  C D Becker; H M Hoogewoud; P Felder; I Gal; P A Ruijs; J Triller
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Sep-Oct       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.